Chief Medical Officer

Role Summary:

The SVP, Chief Medical Officer (CMO) is Dexcom’s senior-most medical leader and the CEO’s primary advisor on clinical strategy, medical credibility, and evidence priorities. The CMO is accountable for enterprise medical strategy, clinical evidence generation, HEOR and real-world evidence, and medical governance across Dexcom’s portfolio in diabetes and metabolic health.

The CMO leads Clinical Affairs and Medical Affairs, with VP-level leaders of each function reporting into the role. The CMO partners closely with Operations & Quality, Regulatory Affairs, Product, Commercial, and Market Access to ensure strong governance, post-market oversight, and consistent, evidence-based medical positioning.

Where you come in:

• Set enterprise medical strategy for Dexcom across diabetes, with strong Type 2 credibility and a clear metabolic health narrative.

• Own the evidence roadmap and ensure the right mix of clinical studies and real-world evidence supports adoption, guidelines, and growth.

• Lead HEOR and RWE efforts, producing payer-ready evidence and reimbursement support in tight partnership with Commercial Market Access.

• Oversee global Medical Affairs including KOL strategy, scientific communications, publications, congress presence, and medical education.

• Chair medical governance and safety oversight for benefit-risk decisions, post-market clinical surveillance input, and medically grounded field actions in partnership with Operations, Quality, and Regulatory.

• Guide portfolio expansion and access pathways including pharmacy and consumer routes where applicable, with evidence-based positioning and appropriate-use guardrails.

• Enable global growth by ensuring medical strategy, evidence, and narratives translate across regions, health systems, and reimbursement environments.

What success looks like:

• A CEO-aligned medical strategy that is clearly anchored in diabetes, with strong Type 2 credibility and a coherent metabolic health narrative.

• A funded evidence roadmap that strengthens differentiation, supports guidelines and access, and enables expansion in Type 2 segments.

• A high-performing HEOR and RWE partnership with Market Access that accelerates coverage expansion and improves credibility of payer narratives.

• Strong medical governance and post-market readiness with clear, timely cross-functional decision-making.

• Increased external credibility through stronger KOL impact, consistent high-trust communications, and higher-quality scientific output.

Required Qualifications:

• MD required; board certification strongly preferred.

• Significant executive leadership in diabetes care or related therapeutic areas, including meaningful exposure to Type 2 diabetes populations and care pathways.

• 15+ years progressive leadership in Clinical Affairs and/or Medical Affairs within regulated medtech, digital health-enabled devices, or closely related environments.

• Demonstrated success building integrated evidence strategies including real-world evidence and HEOR, with examples of influencing adoption, access, and standard-of-care narratives.

• Executive presence and ability to partner effectively with CEO and ELT and cross-functional leaders across Market Access, Operations & Quality, Regulatory, Product, and Commercial in a publicly traded environment.

Preferred Experience:

• Metabolic health experience beyond diabetes, including consumer engagement and behavior change programs.

• Health and wellness exposure, particularly if paired with strong medical governance and appropriate-use discipline.

• Global medical affairs experience supporting international access expansion.

Please note: The information contained herein is not intended to be an all-inclusive list of the duties and responsibilities of the job, nor are they intended to be an all-inclusive list of the skills and abilities required to do the job. Management may, at its discretion, assign or reassign duties and responsibilities to this job at any time. The duties and responsibilities in this job description may be subject to change at any time due to reasonable accommodation or other reasons. Reasonable accommodations may be made to enable individuals with disabilities to perform essential functions.

An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, or protected veteran status and will not be discriminated against on the basis of disability. Dexcom’s AAP may be viewed upon request by contacting Talent Acquisition at [email protected].

If you are an individual with a disability and would like to request a reasonable accommodation as part of the employment selection process, please contact Dexcom Talent Acquisition at [email protected].

Meritain, an Aetna Company, creates and publishes the Machine-Readable Files on behalf of Dexcom. To link to the Machine-Readable Files, please click on the URL provided: https://health1.meritain.com/app/public/#/one/insurerCode=MERITAIN_I&brandCode=MERITAINOVER/machine-readable-transparency-in-coverage?reportingEntityType=TPA_19874&lock=true

To all Staffing and Recruiting Agencies: Our Careers Site is only for individuals seeking a job at Dexcom. Only authorized staffing and recruiting agencies may use this site or to submit profiles, applications or resumes on specific requisitions. Dexcom does not accept unsolicited resumes or applications from agencies. Please do not forward resumes to the Talent Acquisition team, Dexcom employees or any other company location. Dexcom is not responsible for any fees related to unsolicited resumes/applications.

Salary:

$231,900.00 - $481,500.00